Middle East and Africa Patient Controlled Injectors Market Growth and Forecast by 2027
Middle East and Africa Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Electronic Injectors, Mechanical Injectors, and Infusion Pumps); Application (Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, and Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies); and Country
- Report Date : Jan 2021
- Report Code : TIPRE00018217
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 103
The Middle East & Africa patient controlled injectors market is expected to reach US$ 371.53 million by 2027 from US$ 157.85 million in 2019; it is estimated to grow at a CAGR of 11.4% from 2020 to 2027.
The increasing chronic diseases prevalence, and rising patient compliance are the key factors driving the growth of patient controlled injectors. However, lack of adoption of patient controlled injectors in emerging countries may hinder the market growth in Middle East & Africa.The patient-controlled injectors are the newest invention in the administration of injections. There are high-unmet needs of people/ HCPs or patients requiring the patient-controlled injectors as it has greater ease and comfort than any other auto-injectors. These are ergonomically developed, and design patient-controlled injectors can help optimize self-care, making it easy for patients to hold the system and administer the dosages at just one press.
Patient controlled Injectors are subcutaneous drug delivery systems that adhere to the body and administer larger volumes (more than 2 mL) of a drug over an extended period. With the use of patient-controlled injectors, dosing errors, microbial contamination risks, and needle stick injuries can be avoided that are caused during parenteral drug administration using injections. In the last few years, the pharmaceutical industry has witnessed the introduction of several innovative interventions for the treatment of various chronic diseases. However, the majority of the available treatment options require parenteral drug administration, frequent dosing, and repeated hospital visits. Therefore, patient controlled injectors are preferred for the treatment of chronic diseases where long-term treatment is necessary. Chronic diseases, such as blood disorder, autoimmune disorders, and various types of cancer, are the leading causes of death and disability.
Cardiovascular diseases (CVDs) are a significant cause of mortality owing to the hectic lifestyle. For Instance, in 2018, Ministry of Health and Prevention report (MHP) has revealed that CVD is a leading cause of mortality in the UAE. Of CVD deaths, 22% were attributable to acute myocardial infarction (AMI), 16% to cerebrovascular disease, 6% to ischaemic heart disease and 5% to hypertension. Many biologics are commercially available for the treatment, but the conventional drug delivery methods are unable to provide accurate dosage. This augments the use of patient controlled injector drug delivery systems that provide targeted drug delivery and prolonged drug residence to the affected areas of the cardiovascular system. Hence, the adoption of patient controlled injectors is likely to increase, thereby propelling the Patient Controlled Injectors market growth.
The COVID-19 has shown substantial effects in Middle East and Africa. The pandemic has affected the research and development activities in these countries. The economic uncertainties and ongoing conflicts are worsening the condition in the region. These factors are expected to negatively impact the growth of the cell line development serum market in the region. However, the recent pandemic is causing turbulence to the economies of the Middle East region. A sudden drop in domestic and external demand for goods and products especially medical devices specially for alternative treatments other than COVID-19, production due to labour shortage are some of the major impacts observed in the region. Additionally, tightened financial condition is also decreasing the overall economic activities in the region. This uncertainty with normal delays often associated with regulatory approvals in low- and middle-income countries is hindering the growth of the market.
Rest of Middle East & Africa Patient Controlled Injectors Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
MIDDLE EAST & AFRICA PATIENT CONTROLLED INJECTORS MARKET SEGMENTATION
By Product
- Electronic Wearable Injector
- Mechanical Wearable Injector
- Infusion Pumps
By Application
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Company Profiles
- Johnson and Johnson Services, Inc.
- Sensile Medical AG (Gerresheimer AG)
- F. HOFFMANN-LA ROCHE LTD
- Ypsomed AG
- Westbourne Medical Limited
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, Distribution Channel, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Patient Controlled Injectors Market – By Product
1.3.2 Middle East & Africa Patient Controlled Injectors Market – By Application
1.3.3 Middle East & Africa Patient Controlled Injectors Market – By Distribution Channel
1.3.4 Middle East & Africa Patient Controlled Injectors Market – By Country
2. Middle East & Africa Patient Controlled Injectors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Patient Controlled Injectors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Patient Controlled Injectors Market - Middle East & Africa PEST Analysis
4.3 Expert Opinion
5. Middle East & Africa Patient Controlled Injectors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Patient Compliance
5.2 Market Restraints
5.2.1 Lack of Adoption in Emerging Countries
5.3 Market Opportunities
5.3.1 Technological Advancements and Design Development
5.4 Future Trends
5.4.1 Consolidation of Market
5.5 Impact Analysis
6. Patient Controlled Injectors Market – Middle East & Africa Analysis
6.1 Middle East & Africa Patient Controlled Injectors Market Revenue Forecasts and Analysis
7. Middle East & Africa Patient Controlled Injectors Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Middle East & Africa Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
7.2.1 Middle East & Africa Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 Electronic Injector
7.3.1 Overview
7.3.2 Middle East & Africa Electronic Injector Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Mechanical Injectors
7.4.1 Overview
7.4.2 Middle East & Africa Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Infusion Pumps
7.5.1 Overview
7.5.2 Middle East & Africa Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
8. Middle East & Africa Patient Controlled Injectors Market Analysis – By Application
8.1 Overview
8.2 Middle East & Africa Patient Controlled Injectors Market, By Application 2019-2027 (%)
8.2.1 Middle East & Africa Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Cancer Treatment
8.3.1 Overview
8.3.2 Middle East & Africa Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Autoimmune Disease
8.4.1 Overview
8.4.2 Middle East & Africa Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Blood Disorders Treatment
8.5.1 Overview
8.5.2 Middle East & Africa Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Middle East & Africa Patient Controlled Injectors Market Analysis – By Distribution Channel
9.1 Overview
9.2 Middle East & Africa Patient Controlled Injectors Market, By Distribution Channel 2019-2027 (%)
9.2.1 Middle East & Africa Patient Controlled Injectors Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Middle East & Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Middle East & Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Mail Order Pharmacies
9.5.1 Overview
9.5.2 Middle East & Africa Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Patient Controlled Injectors Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Middle East & Africa Patient Controlled Injectors Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Middle East & Africa: Patient Controlled Injectors Market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 Middle East & Africa Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4 Middle East & Africa Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.1.5 Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Middle East & Africa: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
10.1.7 UAE: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 UAE: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 UAE Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 UAE Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.7.4 UAE Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 Saudi Arabia: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Saudi Arabia: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Saudi Arabia Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Saudi Arabia Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.1.8.4 Saudi Arabia Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 South Africa: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 South Africa: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 South Africa Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.30
10.30.1.1 South Africa Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.30.1.2 South Africa Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.30.2 Rest of Middle East and Africa: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.30.2.1 Rest of Middle East and Africa: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
10.30.2.2 Rest of Middle East and Africa Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.30.2.3 Rest of Middle East and Africa Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
10.30.2.4 Rest of Middle East and Africa Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Middle East & Africa Patient Controlled Injectors Market
11.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Sensile Medical AG (Gerresheimer AG)
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ypsomed AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Westbourne Medical Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson and Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. Middle East & Africa Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Middle East & Africa Patient Controlled Injectors Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 4. Middle East & Africa Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. Middle East & Africa Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 6. Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. UAE Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. UAE Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 9. UAE Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. Saudi Arabia Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Saudi Arabia Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 12. Saudi Arabia Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. South Africa Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. South Africa Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 15. South Africa Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of Middle East and Africa Patient Controlled Injectors Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of Middle East and Africa Patient Controlled Injectors Market, by Application– Revenue and Forecast to 2027(USD Million)
Table 18. Rest of Middle East and Africa Patient Controlled Injectors Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 19. Glossary of Terms, Patient Controlled Injectors Market
LIST OF FIGURES
Figure 1. Patient Controlled Injectors Market Segmentation
Figure 2. Middle East & Africa Patient Controlled Injectors Market Overview
Figure 3. Electronic Injector Segment Held Largest Share of Product in Patient Controlled Injectors Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Middle East & Africa Patient Controlled Injectors Market - Leading Country Markets (US$ Mn)
Figure 6. Patient Controlled Injectors Market - Middle East & Africa PEST Analysis
Figure 7. Patient Controlled Injectors Market Impact Analysis of Driver and Restraints
Figure 8. Middle East & Africa Patient Controlled Injectors market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Middle East & Africa Patient Controlled Injectors Market, By Product 2019 & 2027 (%)
Figure 10. Middle East & Africa Electronic Injector Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Middle East & Africa Mechanical Injectors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Middle East & Africa Infusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Middle East & Africa Patient Controlled Injectors Market, by Application 2019 & 2027 (%)
Figure 14. Middle East & Africa Cancer Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Middle East & Africa Autoimmune Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Middle East & Africa Blood Disorders Treatment Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Middle East & Africa Patient Controlled Injectors Market, by Distribution Channel 2019 & 2027 (%)
Figure 19. Middle East & Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Middle East & Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Middle East & Africa Mail Order Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Middle East & Africa: Patient Controlled Injectors Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. Middle East & Africa Patient Controlled Injectors Market Revenue and Forecast to 2027 (USD Million)
Figure 24. Middle East & Africa: Patient Controlled Injectors Market, by Country, 2019 & 2027 (%)
Figure 25. UAE: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Saudi Arabia: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. South Africa: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Rest of Middle East and Africa: Patient Controlled Injectors Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Impact Of COVID-19 Pandemic in Middle East and Africa Market
- Johnson and Johnson Services, Inc.
- Sensile Medical AG (Gerresheimer AG)
- F. HOFFMANN-LA ROCHE LTD
- Ypsomed AG
- Westbourne Medical Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For